Evidence map›Paper›PMID 41089138›Full record

ArticleCureus2025

Isolated Transaminitis as a Sentinel Sign of Duchenne Muscular Dystrophy in an Infant: A Case Report.

Ayesha Khalid, Tuba Chaudhry, Ayesha Liaqat, Lauren Tufts

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ayesha KhalidPediatrics, Marshall University Joan C. Edwards School of Medicine, Huntington, USA.
Tuba ChaudhryPediatrics, Marshall University Joan C. Edwards School of Medicine, Huntington, USA.
Ayesha LiaqatPediatric Emergency Medicine, LSU Health New Orleans School of Medicine, New Orleans, USA.
Lauren TuftsPediatrics, Marshall University Joan C. Edwards School of Medicine, Huntington, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Duchenne muscular dystrophy (DMD) is an X-linked recessive muscular dystrophy (MD) that typically presents after ambulation due to progressive proximal muscle weakness. The average age of diagnosis is 4.83 years. However, there are some subtle signs that can help in early diagnosis and delay the progression of the disease. We present a non-classical DMD case in a six-month-old infant with failure to thrive, persistent emesis, transaminitis, and truncal weakness, leading to an early diagnosis of DMD. Initial workup for failure to thrive was unremarkable, other than persistently elevated liver enzymes aspartate aminotransferase (AST) and alanine transaminase (ALT) with normal alkaline phosphatase and bilirubin. Extensive work to rule out gastrointestinal (GI) pathology, lysosomal, and glycogen storage diseases was unremarkable. Significantly elevated creatine kinase (CK: 6,988 U/L), aldolase (>56 U/L), and low alanine (172.4 µmol/L) raised suspicion for MD. Genetic testing confirmed a hemizygous DMD mutation. After nutritional adjustments, the patient gained appropriate weight. He was referred for long-term neuromuscular care. This case underscores the need to recognize atypical DMD presentations, particularly in infants with GI symptoms and unexplained transaminitis. It highlights the importance of CK testing in cases of isolated AST/ALT elevation with a negative GI workup. Early genetic diagnosis is crucial for timely intervention and improved long-term outcomes.

Indexed as

creatine kinase (ck)duchenne muscular dystrophyfailure to thrivemuscle weakness in infantsneuromuscular disorderstransaminitisx-linked recessive disorders

Identifiers

PMID41089138
PMCPMC12517537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.